Virus Genome Detection - Respiratory Virus Panel 2 (432)

Samples:

4 samples of 1.5 ml

Sample properties:

Lyophilised cell culture material

Additional Information:

The requirements of the RiliBÄK (Guidelines of the German Medical Association on quality assurance in medical laboratory testing / Bundesärztekammer) will be considered for the detection of the above-mentioned pathogens. This EQA scheme is not suitable for (I) tests for antigen detection, (II) testing of sensitivity and (III) typing. For this purpose, we refer to the INSTAND EQA schemes for the corresponding viruses. Orders for EQA schemes from non-EU countries can only be processed by INSTAND e.V. if the ordering laboratories provide a fully completed end-use declaration, a company profile including contact details (e.g. an extract from the website) and, where applicable, an import licence! If these documents are not received by the registration/withdrawal deadline, the registration will unfortunately have to be cancelled. Please also note the dispatch information in this regard.

Requirement for EQAS/PT according to Rili-BÄK

Certificate Validity: 12 months

Not subject to Rili-BÄK

Parameters:

Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for simultaneous qualitative detection of influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated).

This program will be completed with currently circulating virus variants.

 

Some of the samples can contain chemically inactivated avian influenza A viruses.

Certificate Validity: not applicable

Shipping Information:

Shipping not cooled

Safety Information:

Process as patient sample material. The participating laboratory must be authorized to perform direct and/or indirect detection of pathogens.

EQAS/PT Experts: